A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjects

NCT06641388 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects (HS)

Interventions

DRUG: Ebronucimab
DRUG: Ebronucimab

Sponsor

Akeso